A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Solid Tumor
Interventions
DRUG

OMX-0407

Dose escalation, Dose expansion

Trial Locations (15)

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

2610

RECRUITING

ZAS Augustinus Afdeling Oncologische Research, Wilrijk

4000

RECRUITING

CHU de Liège, Liège

9000

RECRUITING

Universitair Ziekenhuis Gent, Ghent

28007

RECRUITING

Hospital Universitario Gregorio Marañon, Madrid

28033

RECRUITING

MD Anderson Cancer Center, Madrid

28040

RECRUITING

START Madrid - Hospital Fundacion Jimenez Diaz, Madrid

28050

RECRUITING

Centro Integral Oncológico Clara Campal, Madrid

46026

RECRUITING

Hospital La Fe de Valencia, Valencia

08906

RECRUITING

ICO Hospitalet, L'Hospitalet de Llobregat

08003

RECRUITING

Hospital del Mar, Barcelona

08035

RECRUITING

Hospital Universitario Vall d'Hebrón, Barcelona

Unknown

RECRUITING

NEXT Oncology - Hospital Quironsalud Barcelona, Barcelona

RECRUITING

NEXT Oncology - Hospital Universitario Quironsalud, Madrid

RECRUITING

Clínica Universidad de Navarra, Pamplona

All Listed Sponsors
lead

iOmx Therapeutics AG

INDUSTRY